SHAWN COFFMAN: Open Payments
NPI 1720022643 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 41 payments from 10 companies in 2025. Trend: 2023 $1,021 · 2024 $858 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 13 | $315 |
| GlaxoSmithKline, LLC. | 14 | $174 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| ABBVIE INC. | 3 | $64 |
| PFIZER INC. | 1 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: NUZYRA, TRELEGY ELLIPTA, LEQVIO, QULIPTA, XHANCE, JYNARQUE, Wegovy, MOUNJARO.
Industry payments across WV — which companies pay providers there.
